A study led by CP3's Tim Anderson on how the 2026 AHA/ACC dyslipidemia guideline expands statin eligibility for primary prevention has drawn wide national media coverage since its publication in JAMA. The study found that the updated guideline makes an additional 21.5 million US adults eligible for statins, bringing total eligibility to 87.5 million adults, or 56.6% of the target population.
Selected coverage:
- CNN: Millions more Americans may now be eligible for statins. What the new cholesterol guidelines mean
- Reuters (Health Rounds): New cardiac guidelines mean more statins for more people, study finds
- Medscape: New Guidelines Expand Statin Eligibility to More Than Half of US Adults
- Additional coverage: U.S. News and World Report/HealthDay, TCTMD, MedPage Today, The Cardiology Advisor, Healio Cardiology, HCP Live, and others.